Condition
Infantile Diarrhea
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Completed2
Unknown2
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07444008Not ApplicableNot Yet Recruiting
Randomized, Blinded, Placebo-Controlled Evaluation of BioAmicus Complete
NCT04262648Not ApplicableCompleted
Randomized Placebo-controlled Study of L. Reuteri NCIMB 30351 in GI Functional Disorders and Food Allergy in Newborns
NCT02870491Not ApplicableCompletedPrimary
Working With Community Health Workers to Increase ORS Use in Uganda
NCT01612572Unknown
A Registry Study on Xiyanping(a Chinese Medicine Injection) Used in Fifty Hospitals
NCT01469273Phase 4UnknownPrimary
Prophylaxis of Gastrointestinal Infections With EcN
Showing all 5 trials